VIB305

· Vibrant Sciences Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIB305, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]